View all cases
UPC APP 3514/2024
EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Case details
- StatusClaim dismissedActionPreliminary objectionCategoryPreliminary objection
- Parties
- Claimants
- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
Representatives- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Robert Knaps-Kather Augenstein
- Thomas Kronbergersupporting-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Roche Diabetes Care GmbHOperating co.
Representatives- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
- Division
- Paris CD
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- May 10, 2024
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris CD | Locked |
| Judge Paolo Catallozzi | Locked |
| Judge Tatyana Zhilova | Locked |
| Judge Giorgio Checcacci | Locked |
At the UPC: Tandem Diabetes Care Group (18 cases)·Roche Group (29 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 11/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023 and 4 more
1 other defendants litigating the same or a related patent
Decisions
- 2024-05-10Preliminary objectionPublic
Summary: The Paris Central Division dismissed a preliminary objection by Tandem Diabetes Care contesting the UPC's jurisdiction based on an alleged violation of a standstill agreement before filing the revocation action by Roche Diabetes Care, ruling that breach of a standstill agreement does not constitute grounds for challenging the court's jurisdiction.
Show the legal issues (4)
- Preliminary objection to jurisdiction (R.19 RoP)
- Standstill agreement and UPC jurisdiction
- Pre-filing notice requirements
- Admissibility of revocation action
Documents
- 3CDE515EC0F26C73D47167805368B7DE_en.pdf2024-05-10EN